Medicare plans are replacing brand-name buprenorphine-naloxone film with its generic equivalents, resulting in a decrease in out-of-pocket cost faced by enrollees with opioid use disorder. Objectives: ...
The exponential rise in opioid prescriptions by pharmaceutical companies, despite awareness of their addictive nature, has led to a staggering toll of over 760,000 lives lost to drug overdoses since ...
On October 19, 2022, U.S. District Judge Mitchell Goldberg in the Eastern District of Pennsylvania granted Aquestive Therapeutics Inc.’s (f/k/a MonoSol Rx LLC) motion for summary judgment in the ...
Add Yahoo as a preferred source to see more of our stories on Google. The Wisconsin Department of Justice along with 40 other states and the District of Columbia has settled a lawsuit for $102.5 ...
Indivior, a pharmaceutical company, has reached a $30 million settlement to resolve a class action lawsuit filed in a U.S. court by health plans. The lawsuit alleges that the company unlawfully ...
For young people with opioid use disorder (OUD), buprenorphine costs have declined overall but with drastic variation by payer type, researchers found. Examining buprenorphine prescriptions dispensed ...
June 2 (Reuters) - Indivior Plc (INDV.L), opens new tab said on Friday it agreed to pay $102.5 million to settle a lawsuit by dozens of U.S. states accusing it of illegally suppressing generic ...
Wisconsin’s Medicaid program will cover a pill form of an addiction treatment drug, in addition to Suboxone film strips — a move sheriffs say might decrease smuggling of the film into jails but ...
The US Food and Drug Administration (FDA) has approved the first generic versions of Suboxone (buprenorphine and naloxone) sublingual film for the treatment of opioid dependence, which may increase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results